GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) » Definitions » Other Income (Expense)

Kunming Longjin Pharmaceutical Co (SZSE:002750) Other Income (Expense) : ¥-20.78 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kunming Longjin Pharmaceutical Co Other Income (Expense)?

Kunming Longjin Pharmaceutical Co's other income expense for the Kunming Longjin Pharmaceutical Co's pretax income for the three months ended in Mar. 2024 was ¥0.49 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-20.78 Mil.

Kunming Longjin Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Kunming Longjin Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kunming Longjin Pharmaceutical Co Other Income (Expense) Chart

Kunming Longjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.18 2.48 -3.33 -35.22 -20.38

Kunming Longjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 1.80 1.22 -24.29 0.49

Kunming Longjin Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-20.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kunming Longjin Pharmaceutical Co  (SZSE:002750) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Kunming Longjin Pharmaceutical Co (SZSE:002750) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:000919 SZSE:301520 SHSE:603168 SZSE:002864 SZSE:002940 SZSE:000788 SHSE:603669 SZSE:002900 SZSE:002923 SHSE:688799 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
789 Lanmao Road, High-tech Zone, Majinpu, Kunming, CHN, 650503
Website
http://www.longjin.com.cn
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.

Kunming Longjin Pharmaceutical Co (SZSE:002750) Headlines

No Headlines